China Updates: China’s PMIs entered the contraction zone as Covid-19 cases resurged China Updates: China’s PMIs entered the contraction zone as Covid-19 cases resurged China Updates: China’s PMIs entered the contraction zone as Covid-19 cases resurged

China Updates: China’s PMIs entered the contraction zone as Covid-19 cases resurged

Macro
Redmond Wong

Market Strategist, Greater China

Summary:  China’s March PMIs showed across the board weaknesses in the economy’s manufacturing activities, new export orders and the service sector. Moreover, resurgence of Covid-19 cases, particularly in major cities such as Shanghai, is dampening China's growth outlook further. According to economists’ estimates, imposing lockdown for half-a-month on Shanghai will knock 4% off China’s GDP during that half-a-month. This translates into a decline in annual national GDP by approximately 0.17%.


March PMIs signaled widespread deceleration in economic activities. China released its March PMI data with across the board weaknesses.  Both Manufacturing and non-manufacturing PMIs fell below 50, the expansion-contraction threshold, to 49.5 (vs 50.2 in Feb.) and 48.4 (vs 51.6 in Feb.) respectively and below already subdue expectations.  Most sub-indices fell from last month and went below 50.  New orders came at 47.2 (vs 49 in Feb.).  Employment and raw materials inventory were down to 48.6 (vs 49.2 in Feb.) and 47.3 (vs 48.1 in Feb) respectively.  Services fell sharply to 46.7 (vs 50.5 in Feb) as this sector was most affected by the Covid related lockdowns and other restrictions on mobility of people.  The only bright spot was construction which is a sub-index under non-manufacturing.  The strength in construction mainly came from infrastructure related construction works.  Separately, the Caixin China PMI Manufacturing, which focused on private industrial companies, also fell to 48.1 in March (vs 50.4 in February).

Exports are not going to help in 2022.  PMI’s New export orders sub-index was 47.2 (vs 49.0 in February).  This, taking together with the negative growth in throughput in the eight largest ports in China recently and declines in China to Europe and the U.S. West coast container freight rates, it is fair to expect that exports, last year’s GDP key growth driver, are set to lose momentum and decelerate in growth. 

Resurgence of Covid-19 outbreaks contributed to the weakness in economic activities .  In China, excluding Hong Kong, the total number of local Covid-19 cases has been subdue over a long period of time unitl February 2022 with the highest daily new cases, including symptomatic and asymptomatic cases, being 223 on Jan 20, 2021.  However, the total number of new cases rose to 505 on March 7, 2022 and then continued to surge exponentially to 8,454 on Mar 30, 2022. These cases spread over 54 high-risk districts and 474 medium-risk districts in 15 provinces, two municipalities and one autonomous region. 

High-risk districts are districts that have more than 50 cumulative cases and a cluster of epidemics occurred in the last 14 days. Medium-risk districts are districts that have newly confirmed cases in the last 14 days but the cumulative number of confirmed cases does not exceed 50, or districts that have cumulative number of confirmed cases exceeding 50 but no cluster of epidemics occurred in the last 14 days.  According to Goldman Sachs’ estimates, cities with high-risk districts accounted for about 10% of China’s national GDP and cities with medium-risk districts represented 20% of national GDP.  Covid related mobility restrictions or even lockdowns in these districts have significantly affected economic activities. 

Expecting lockdowns as Covid outbreaks persist. Ahead of the Chinese Communist Party’s all important 20th Party Congress that is going to determine the leadership in the next five or even 10 years, large-scale Covid infection and mortality are simply unacceptable and out of the question for the Chinese authorities.  As discussed in our previous note, China prides its effective administration of the “zero-Covid approach” for the Chinese economy’s impressive rebound from the pandemic before everyone else in 2021.  It has been advocating to the country’s population as well as the rest of the world that this success as demonstration of President’s Xi’s socialism with Chinese characteristics for a new era. Although Xi Jinping said that “more effective measures should be taken to achieve maximum effect in prevention and control with minimum cost, and to reduce the impact on socioeconomic development as much as possible” in a meeting of the Central Committee of the Chinese Communist Party’s Politburo on March 17, 2022, it is unlikely for abandonment of the “dynamic zero-Covid” approach to happen and lockdowns are still to be expected when outbreaks persist. 

Recent and future lockdowns will make China’s 5.5% GDP growth target for 2022 a huge challenge. Of the 8,454 cases on Mar 30, 2022, 5,301 cases or 62.7% are in Shanghai.  It is worth to note that the March PMI survey took place before the staggered lockdown of Shanghai for mass Covid tests started on March 28, 2022.  It is likely that the April PMI, once having taken in the full impact of the more recent surge of cases and the Shanghai staggered lockdown, will decelerate further.  During the lockdown, many factories have suspended production, including Tesla’s plant in Shanghai. The mobility of people came to a halt and trucking capacity was reportedly cut by 30%.  According to Nomura Securities, Maersk, the Danish container shipping giant, has closed its counter office and all of its warehouses in Shanghai from March 28, 2022 and the number of cargo ships queuing outside of the ports in Shanghai and nearby Ningbo have increased from 120 vessels to 168 as of March 30, 2022.  

A recent economic research paper (Chen et al, 2022) uses historical data of changes in truck flows from 16 whole-city lockdowns and 18 partial (i.e. only some but not all counties/districts in a city) lockdowns in Chinese cities to estimate the economic cost of lockdown in China. Its findings suggest that the imposition of a full-scale lockdown for half-a-month on Shanghai will knock 4% off China’s GDP during that half-a-month.  This implies a decline in annual national GDP by approximately 0.17%.  It is also estimated that imposing one-month full-scale lockdown on China’s four largest 4 cities (Beijing, Guangzhou, Shanghai and Shenzhen) at the same time, the four cities will lose their real income by 61% for that month and the national GDP would fall by 12% for that month or approximately 1% for the year. This estimated cost is substantially higher than the 1% national annual GDP loss from a 4-week lockdown of all the high-risk and medium risk districts being put forwarded by Goldman Sachs.   Escalation of lockdowns will be costly and make China’s 5.5% GDP growth target increasingly challenging. 

Source: Saxo Markets, Bloomberg LP
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.